Haleon plc
NYSE: HLN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
Updated 2026-09-11
Haleon plc (HLN) Financial statements
SEC filings — annual and quarterly data.
Margin trends — annual
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $8.48B | $655.00M | 56.63% | 10.58% | 7.72% |
| 2020 | $9.89B | $1.15B | 59.75% | 16.15% | 11.58% |
| 2021 | $9.54B | $1.39B | 62.34% | 17.16% | 14.56% |
| 2022 | $10.86B | $1.06B | 60.57% | 16.81% | 9.76% |
| 2023 | $11.30B | $1.05B | 61.59% | 17.66% | 9.28% |
| 2024 | $11.23B | $1.44B | 61.85% | 19.64% | 12.84% |
| 2025 | $11.03B | $1.63B | 63.35% | 21.87% | 14.78% |
Frequently asked questions
What is Haleon plc's revenue?
Haleon plc's trailing twelve-month revenue is $11.15B, and consensus projects about $13.40B by 2030. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How profitable is HLN?
In its most recent fiscal year, HLN ran a gross margin of 63.35%, an operating margin of 21.87%, and a net margin of 14.78%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.
How much free cash flow does HLN generate?
HLN produced $1.97B in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is HLN's balance sheet healthy?
HLN holds $1.32B in cash and equivalents against $7.66B in long-term debt, on $16.40B of shareholder equity. That debt is best read against the cash flow the business throws off each year.